APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-opioid Analgesic Patch

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Non-opioid Analgesic Patch Market Outlook and Growth Opportunities 2026

27 December 2025193 pages

Choose your research edition.

Industry ResearchNon-opioid Analgesic Patch Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-opioid Analgesic Patch Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Non-opioid Analgesic Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-opioid Analgesic Patch Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-opioid Analgesic Patch Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Non-opioid Analgesic Patch market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Non-opioid Analgesic Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-opioid Analgesic Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-opioid Analgesic Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Non-opioid Analgesic Patch market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Non-opioid Analgesic Patch market include Acorda Therapeutics, Inc, Allergan, Endo International plc, Hisamitsu Pharmaceutical Co.,Inc, IBSA Institut Biochimque SA, Teh Seng Pharmaceutical Mfg, Teikoku Seiyaku Co., Ltd., GlaxoSmithKline Plc and Pfizer, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Non-opioid Analgesic Patch market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-opioid Analgesic Patch and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-opioid Analgesic Patch revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Non-opioid Analgesic Patch market.

Non-opioid Analgesic Patch Segment by Company

Acorda Therapeutics, Inc

Allergan

Endo International plc

Hisamitsu Pharmaceutical Co.,Inc

IBSA Institut Biochimque SA

Teh Seng Pharmaceutical Mfg

Teikoku Seiyaku Co., Ltd.

GlaxoSmithKline Plc

Pfizer, Inc.

Mylan N.V.

Non-opioid Analgesic Patch Segment by Type

Capsaicin Patches

Lidocaine Patches

Diclofenac Patches

Methyl Salicylate Patches

Ketoprofen Patches

Others

Non-opioid Analgesic Patch Segment by Application

Hospital Pharmacies

Online Pharmacies

Independent Pharmacies & Drug Stores

Non-opioid Analgesic Patch Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Non-opioid Analgesic Patch status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Non-opioid Analgesic Patch key companies, revenue, market share, and recent developments.

3. To split the Non-opioid Analgesic Patch breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Non-opioid Analgesic Patch market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Non-opioid Analgesic Patch significant trends, drivers, influence factors in global and regions.

6. To analyze Non-opioid Analgesic Patch competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-opioid Analgesic Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-opioid Analgesic Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-opioid Analgesic Patch.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non-opioid Analgesic Patch industry.

Chapter 3: Detailed analysis of Non-opioid Analgesic Patch company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Non-opioid Analgesic Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Non-opioid Analgesic Patch in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Non-opioid Analgesic Patch Industry Trends Table 2. Non-opioid Analgesic Patch Industry Drivers Table 3. Non-opioid Analgesic Patch Industry Opportunities and Challenges Table 4. Non-opioid Analgesic Patch Industry Restraints Table 5. Global Non-opioid Analgesic Patch Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Non-opioid Analgesic Patch Revenue Share by Company (2021-2026) Table 7. Global Non-opioid Analgesic Patch Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Non-opioid Analgesic Patch Key Company Manufacturing Base & Headquarters Table 9. Global Non-opioid Analgesic Patch Company, Product Type & Application Table 10. Global Non-opioid Analgesic Patch Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Non-opioid Analgesic Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Capsaicin Patches Table 15. Significant Companies of Lidocaine Patches Table 16. Significant Companies of Diclofenac Patches Table 17. Significant Companies of Methyl Salicylate Patches Table 18. Significant Companies of Ketoprofen Patches Table 19. Significant Companies of Others Table 20. Global Non-opioid Analgesic Patch Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Non-opioid Analgesic Patch Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Non-opioid Analgesic Patch Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Non-opioid Analgesic Patch Sales Value Share by Type (2021-2026) Table 24. Global Non-opioid Analgesic Patch Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Hospital Pharmacies Table 26. Significant Companies of Online Pharmacies Table 27. Significant Companies of Independent Pharmacies & Drug Stores Table 28. Global Non-opioid Analgesic Patch Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Non-opioid Analgesic Patch Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Non-opioid Analgesic Patch Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Non-opioid Analgesic Patch Sales Value Share by Application (2021-2026) Table 32. Global Non-opioid Analgesic Patch Sales Value Share by Application (2027-2032) Table 33. Global Non-opioid Analgesic Patch Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Non-opioid Analgesic Patch Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Non-opioid Analgesic Patch Sales Value Share by Region (2021-2026) Table 36. Global Non-opioid Analgesic Patch Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Non-opioid Analgesic Patch Sales Value Share by Region (2027-2032) Table 38. Global Non-opioid Analgesic Patch Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Non-opioid Analgesic Patch Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Non-opioid Analgesic Patch Sales Value Market Share by Country (2021-2026) Table 41. Global Non-opioid Analgesic Patch Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Non-opioid Analgesic Patch Sales Value Market Share by Country (2027-2032) Table 43. Acorda Therapeutics, Inc Company Information Table 44. Acorda Therapeutics, Inc Business Overview Table 45. Acorda Therapeutics, Inc Non-opioid Analgesic Patch Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Acorda Therapeutics, Inc Non-opioid Analgesic Patch Product Portfolio Table 47. Acorda Therapeutics, Inc Recent Development Table 48. Allergan Company Information Table 49. Allergan Business Overview Table 50. Allergan Non-opioid Analgesic Patch Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Allergan Non-opioid Analgesic Patch Product Portfolio Table 52. Allergan Recent Development Table 53. Endo International plc Company Information Table 54. Endo International plc Business Overview Table 55. Endo International plc Non-opioid Analgesic Patch Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Endo International plc Non-opioid Analgesic Patch Product Portfolio Table 57. Endo International plc Recent Development Table 58. Hisamitsu Pharmaceutical Co.,Inc Company Information Table 59. Hisamitsu Pharmaceutical Co.,Inc Business Overview Table 60. Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Product Portfolio Table 62. Hisamitsu Pharmaceutical Co.,Inc Recent Development Table 63. IBSA Institut Biochimque SA Company Information Table 64. IBSA Institut Biochimque SA Business Overview Table 65. IBSA Institut Biochimque SA Non-opioid Analgesic Patch Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. IBSA Institut Biochimque SA Non-opioid Analgesic Patch Product Portfolio Table 67. IBSA Institut Biochimque SA Recent Development Table 68. Teh Seng Pharmaceutical Mfg Company Information Table 69. Teh Seng Pharmaceutical Mfg Business Overview Table 70. Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Product Portfolio Table 72. Teh Seng Pharmaceutical Mfg Recent Development Table 73. Teikoku Seiyaku Co., Ltd. Company Information Table 74. Teikoku Seiyaku Co., Ltd. Business Overview Table 75. Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Product Portfolio Table 77. Teikoku Seiyaku Co., Ltd. Recent Development Table 78. GlaxoSmithKline Plc Company Information Table 79. GlaxoSmithKline Plc Business Overview Table 80. GlaxoSmithKline Plc Non-opioid Analgesic Patch Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. GlaxoSmithKline Plc Non-opioid Analgesic Patch Product Portfolio Table 82. GlaxoSmithKline Plc Recent Development Table 83. Pfizer, Inc. Company Information Table 84. Pfizer, Inc. Business Overview Table 85. Pfizer, Inc. Non-opioid Analgesic Patch Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Pfizer, Inc. Non-opioid Analgesic Patch Product Portfolio Table 87. Pfizer, Inc. Recent Development Table 88. Mylan N.V. Company Information Table 89. Mylan N.V. Business Overview Table 90. Mylan N.V. Non-opioid Analgesic Patch Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Mylan N.V. Non-opioid Analgesic Patch Product Portfolio Table 92. Mylan N.V. Recent Development Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Non-opioid Analgesic Patch Product Image Figure 2. Global Non-opioid Analgesic Patch Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-opioid Analgesic Patch Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-opioid Analgesic Patch Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Capsaicin Patches Image Figure 8. Lidocaine Patches Image Figure 9. Diclofenac Patches Image Figure 10. Methyl Salicylate Patches Image Figure 11. Ketoprofen Patches Image Figure 12. Others Image Figure 13. Global Non-opioid Analgesic Patch Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Non-opioid Analgesic Patch Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Non-opioid Analgesic Patch Sales Value Share by Type (2021-2032) Figure 16. Hospital Pharmacies Image Figure 17. Online Pharmacies Image Figure 18. Independent Pharmacies & Drug Stores Image Figure 19. Global Non-opioid Analgesic Patch Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Non-opioid Analgesic Patch Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Non-opioid Analgesic Patch Sales Value Share by Application (2021-2032) Figure 22. Global Non-opioid Analgesic Patch Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Non-opioid Analgesic Patch Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Non-opioid Analgesic Patch Sales Value (2021-2032) & (US$ Million) Figure 25. North America Non-opioid Analgesic Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Non-opioid Analgesic Patch Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Non-opioid Analgesic Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Non-opioid Analgesic Patch Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Non-opioid Analgesic Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Non-opioid Analgesic Patch Sales Value (2021-2032) & (US$ Million) Figure 31. South America Non-opioid Analgesic Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Non-opioid Analgesic Patch Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Non-opioid Analgesic Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Capsaicin Patches
  • Lidocaine Patches
  • Diclofenac Patches
  • Methyl Salicylate Patches
  • Ketoprofen Patches
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Independent Pharmacies & Drug Stores
Companies covered
  • Acorda Therapeutics, Inc
  • Allergan
  • Endo International plc
  • Hisamitsu Pharmaceutical Co.,Inc
  • IBSA Institut Biochimque SA
  • Teh Seng Pharmaceutical Mfg
  • Teikoku Seiyaku Co., Ltd.
  • GlaxoSmithKline Plc
  • Pfizer, Inc.
  • Mylan N.V.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Non-opioid Analgesic Patch Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Non-opioid Analgesic Patch Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Non-opioid Analgesic Patch Market Dynamics
  1. 2.1 Non-opioid Analgesic Patch Industry Trends
  2. 2.2 Non-opioid Analgesic Patch Industry Drivers
  3. 2.3 Non-opioid Analgesic Patch Industry Opportunities and Challenges
  4. 2.4 Non-opioid Analgesic Patch Industry Restraints
3 Non-opioid Analgesic Patch Market by Company
  1. 3.1 Global Non-opioid Analgesic Patch Company Revenue Ranking in 2025
  2. 3.2 Global Non-opioid Analgesic Patch Revenue by Company (2021-2026)
  3. 3.3 Global Non-opioid Analgesic Patch Company Ranking (2024-2026)
  4. 3.4 Global Non-opioid Analgesic Patch Company Manufacturing Base and Headquarters
  5. 3.5 Global Non-opioid Analgesic Patch Company Product Type and Application
  6. 3.6 Global Non-opioid Analgesic Patch Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Non-opioid Analgesic Patch Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Non-opioid Analgesic Patch Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Non-opioid Analgesic Patch Market by Type
  1. 4.1 Non-opioid Analgesic Patch Type Introduction
  2. 4.1.1 Capsaicin Patches
  3. 4.1.2 Lidocaine Patches
  4. 4.1.3 Diclofenac Patches
  5. 4.1.4 Methyl Salicylate Patches
  6. 4.1.5 Ketoprofen Patches
  7. 4.1.6 Others
  8. 4.2 Global Non-opioid Analgesic Patch Sales Value by Type
  9. 4.2.1 Global Non-opioid Analgesic Patch Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Non-opioid Analgesic Patch Sales Value by Type (2021-2032)
  11. 4.2.3 Global Non-opioid Analgesic Patch Sales Value Share by Type (2021-2032)
5 Non-opioid Analgesic Patch Market by Application
  1. 5.1 Non-opioid Analgesic Patch Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Independent Pharmacies & Drug Stores
  5. 5.2 Global Non-opioid Analgesic Patch Sales Value by Application
  6. 5.2.1 Global Non-opioid Analgesic Patch Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Non-opioid Analgesic Patch Sales Value by Application (2021-2032)
  8. 5.2.3 Global Non-opioid Analgesic Patch Sales Value Share by Application (2021-2032)
6 Non-opioid Analgesic Patch Regional Value Analysis
  1. 6.1 Global Non-opioid Analgesic Patch Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-opioid Analgesic Patch Sales Value by Region (2021-2032)
  3. 6.2.1 Global Non-opioid Analgesic Patch Sales Value by Region: 2021-2026
  4. 6.2.2 Global Non-opioid Analgesic Patch Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Non-opioid Analgesic Patch Sales Value (2021-2032)
  7. 6.3.2 North America Non-opioid Analgesic Patch Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Non-opioid Analgesic Patch Sales Value (2021-2032)
  10. 6.4.2 Europe Non-opioid Analgesic Patch Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Non-opioid Analgesic Patch Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Non-opioid Analgesic Patch Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Non-opioid Analgesic Patch Sales Value (2021-2032)
  16. 6.6.2 South America Non-opioid Analgesic Patch Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Non-opioid Analgesic Patch Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Non-opioid Analgesic Patch Sales Value Share by Country, 2025 VS 2032
7 Non-opioid Analgesic Patch Country-level Value Analysis
  1. 7.1 Global Non-opioid Analgesic Patch Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Non-opioid Analgesic Patch Sales Value by Country (2021-2032)
  3. 7.2.1 Global Non-opioid Analgesic Patch Sales Value by Country (2021-2026)
  4. 7.2.2 Global Non-opioid Analgesic Patch Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Non-opioid Analgesic Patch Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Non-opioid Analgesic Patch Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Non-opioid Analgesic Patch Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Acorda Therapeutics, Inc
  2. 8.1.1 Acorda Therapeutics, Inc Company Information
  3. 8.1.2 Acorda Therapeutics, Inc Business Overview
  4. 8.1.3 Acorda Therapeutics, Inc Non-opioid Analgesic Patch Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Acorda Therapeutics, Inc Non-opioid Analgesic Patch Product Portfolio
  6. 8.1.5 Acorda Therapeutics, Inc Recent Developments
  7. 8.2 Allergan
  8. 8.2.1 Allergan Company Information
  9. 8.2.2 Allergan Business Overview
  10. 8.2.3 Allergan Non-opioid Analgesic Patch Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Allergan Non-opioid Analgesic Patch Product Portfolio
  12. 8.2.5 Allergan Recent Developments
  13. 8.3 Endo International plc
  14. 8.3.1 Endo International plc Company Information
  15. 8.3.2 Endo International plc Business Overview
  16. 8.3.3 Endo International plc Non-opioid Analgesic Patch Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Endo International plc Non-opioid Analgesic Patch Product Portfolio
  18. 8.3.5 Endo International plc Recent Developments
  19. 8.4 Hisamitsu Pharmaceutical Co.,Inc
  20. 8.4.1 Hisamitsu Pharmaceutical Co.,Inc Company Information
  21. 8.4.2 Hisamitsu Pharmaceutical Co.,Inc Business Overview
  22. 8.4.3 Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Product Portfolio
  24. 8.4.5 Hisamitsu Pharmaceutical Co.,Inc Recent Developments
  25. 8.5 IBSA Institut Biochimque SA
  26. 8.5.1 IBSA Institut Biochimque SA Company Information
  27. 8.5.2 IBSA Institut Biochimque SA Business Overview
  28. 8.5.3 IBSA Institut Biochimque SA Non-opioid Analgesic Patch Revenue and Gross Margin (2021-2026)
  29. 8.5.4 IBSA Institut Biochimque SA Non-opioid Analgesic Patch Product Portfolio
  30. 8.5.5 IBSA Institut Biochimque SA Recent Developments
  31. 8.6 Teh Seng Pharmaceutical Mfg
  32. 8.6.1 Teh Seng Pharmaceutical Mfg Company Information
  33. 8.6.2 Teh Seng Pharmaceutical Mfg Business Overview
  34. 8.6.3 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Product Portfolio
  36. 8.6.5 Teh Seng Pharmaceutical Mfg Recent Developments
  37. 8.7 Teikoku Seiyaku Co., Ltd.
  38. 8.7.1 Teikoku Seiyaku Co., Ltd. Company Information
  39. 8.7.2 Teikoku Seiyaku Co., Ltd. Business Overview
  40. 8.7.3 Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Product Portfolio
  42. 8.7.5 Teikoku Seiyaku Co., Ltd. Recent Developments
  43. 8.8 GlaxoSmithKline Plc
  44. 8.8.1 GlaxoSmithKline Plc Company Information
  45. 8.8.2 GlaxoSmithKline Plc Business Overview
  46. 8.8.3 GlaxoSmithKline Plc Non-opioid Analgesic Patch Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GlaxoSmithKline Plc Non-opioid Analgesic Patch Product Portfolio
  48. 8.8.5 GlaxoSmithKline Plc Recent Developments
  49. 8.9 Pfizer, Inc.
  50. 8.9.1 Pfizer, Inc. Company Information
  51. 8.9.2 Pfizer, Inc. Business Overview
  52. 8.9.3 Pfizer, Inc. Non-opioid Analgesic Patch Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer, Inc. Non-opioid Analgesic Patch Product Portfolio
  54. 8.9.5 Pfizer, Inc. Recent Developments
  55. 8.10 Mylan N.V.
  56. 8.10.1 Mylan N.V. Company Information
  57. 8.10.2 Mylan N.V. Business Overview
  58. 8.10.3 Mylan N.V. Non-opioid Analgesic Patch Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Mylan N.V. Non-opioid Analgesic Patch Product Portfolio
  60. 8.10.5 Mylan N.V. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst